10 Top Penny Stocks To Buy Under $5 That Are Household Names

the latest tech news, global tech news daily, tech news today, startups, usa tech, asia tech, china tech, eu tech, global tech, in-depth electronics reviews, 24h tech news, 24h tech news, top mobile apps, tech news daily, gaming hardware, big tech news, useful technology tips, expert interviews, reporting on the business of technology, venture capital funding, programing language

If you’re a traditional investor, you’ve probably heard the saying “invest in what you know.” This is a very basic strategy in the stock market today that entails buying shares of companies you use frequently.

penny stocks, NASDAQ:SNAX, NASDAQ:ME, NASDAQ:BZFD, NYSE:HIMS, NYSE:BODY, CLICK HERE RIGHT NOW!
PennyStocks.com – PennyStocks

Do you drink Starbucks coffee every day? Why not invest in Starbucks stock? Like McDonald’s cheeseburgers? Why not invest in the company?

the latest tech news, global tech news daily, tech news today, startups, usa tech, asia tech, china tech, eu tech, global tech, in-depth electronics reviews, 24h tech news, 24h tech news, top mobile apps, tech news daily, gaming hardware, big tech news, useful technology tips, expert interviews, reporting on the business of technology, venture capital funding, programing language

This is one of the tenets of famous investor Warren Buffett though it’s much more detailed than buying into a company you know well.

This idea has also influenced certain penny stocks, believe it or not. Today we’ll look at five more household names that are not only public companies but area also trading as penny stocks right now. This adds to our original list from the article: 5 Household Name Penny Stocks To Buy Under $5.

Stryve Foods, Inc. (NASDAQ:SNAX)

Global Tech News Daily

We’ll start this list of household penny stocks with what may be the lesser-known of the bunch. You might’ve seen advertisements for something that looked like salami or jerky. It’s called “biltong,” and the “Biltong Slab” from Stryve is presented as a high-quality beef perfect for those on a keto diet. The company was also selling it alongside a meat slicer to attract holiday shoppers late last year.

penny stocks, NASDAQ:SNAX, NASDAQ:ME, NASDAQ:BZFD, NYSE:HIMS, NYSE:BODY, CLICK HERE RIGHT NOW!

Regardless of the vibrant packaging and unique value proposition during the holidays, SNAX stock hasn’t brought such “tasty” returns to the market quite yet. Since going public, shares have slid from over $5 to under $3. A recent $35 million public offering also added pressure to the stock. However, the use of proceeds was clearly outlined in going toward Stryve’s current growth model.

Global Tech News Daily

Over the last few months, the company sagged distribution wins through deals with Costco, Walmart, and 7-Eleven, and plans to continue this growth. CEO Joe Oblas expects the short-term stalemate to “pave the way” for brand growth in the future. Helping with this is a focus on endorsement and influencer deals with notable athletes. This month, Stryve signed Tennis Pro Taylor Fritz as its newest brand ambassador, helping to educate consumers on “healthy snacking” lifestyles.

  • Trading Penny Stocks? Top Stock Market News for January 26th, 2022

From a market perspective, it may also be worth noting that SNAX stock has come into a retail trading spotlight as a lower float name. This theme seems to be popular this year among day and swing traders thanks to the potential for higher volatility.

23andMe Holding Co. (NASDAQ:ME)

penny stocks, NASDAQ:SNAX, NASDAQ:ME, NASDAQ:BZFD, NYSE:HIMS, NYSE:BODY, CLICK HERE RIGHT NOW!

Something that may be a bit more notable is 23andMe Holding Co. The company went public via SPAC last year and ultimately reached a high of $13.68 in the middle of the 4th quarter. Since then, however, the DNA of the market hasn’t been strong. In fact, during the last two and a half months, ME stock has slipped by as much as 70%. This week, shares reached new 52-week lows of $3.99.

What is 23andMe? It’s a consumer genetics company made popular by its genetic test kit. You may not know that the company is also developing a scientific and therapeutics side. It has multiple FDA authorizations for genetic health risk reports. The company has also generated over 180 publications on genetic traits. These relate to a broad range of diseases and conditions. Its 23andMe Therapeutics group is pursuing drug discovery programs based on genetics for oncology and cardiovascular diseases, among others.

Earlier this month, the company received FDA Clearance for a direct-to-consumer genetic test on a hereditary prostate cancer market. 23andMe is also collaborating with GlaxoSmithKline on an immuno-oncology antibody program. Recently extended through next summer, 23andMe is entitled to receive a one-time, $50 million payment for the extension.

The two companies are working on a program to target CD96 (GSK 608) currently in Phase 1 studies. “we are hopeful that targeting CD96 will have the potential to provide cancer patients with a new medicine in the fight against cancer,” explained Kenneth Hillan, Head of Therapeutics at 23andMe in a January PR.

BuzzFeed, Inc. (NASDAQ:BZFD)

penny stocks, NASDAQ:SNAX, NASDAQ:ME, NASDAQ:BZFD, NYSE:HIMS, NYSE:BODY, CLICK HERE RIGHT NOW!

Yes, this is the same BuzzFeed you’ve followed on Facebook, Instagram, Twitter, TikTok, and other platforms. Blank check company 890 5th Avenue Partners approved a SPAC merger with Buzzfeed late last year, which saw the media organization make its public debut at an opening price of $10.95. Since then, it has been in a slow and steady decline, reaching new lows of $3.80 this week.

The digital media company’s brand portfolio isn’t limited to just its Buzzfeed flagship. It also includes Complex Networks, HuffPost, and Tasty Lifestyle Brands, to name a few. According to the company, 740 million hours of content alone were consumed in 2020 and is #1 in time spent among Gen Z and Millennials.

Despite the negative move in the market, analysts seem to be bullish right now. This month, Cowen and Craig Hallum initiated coverage on BZFD stock with Outperform and Buy ratings. These also came with price targets ranging between $7 and $7.50.

Along with a sizeable 27.9% stake from Comcast and a new 13.8% stake from New Enterprise Associates, there’s no shortage of notable names investing in the penny stock right now. Will it help reenergize a bullish Buzz around the company this year?

Hims & Hers Health, Inc. (NYSE:HIMS)

penny stocks, NASDAQ:SNAX, NASDAQ:ME, NASDAQ:BZFD, NYSE:HIMS, NYSE:BODY, CLICK HERE RIGHT NOW!

If you’re on the hunt for an “exciting” name in the stock market today, Hims & Hers Health has built its brand by arousing customer loyalty. The company specializes in is designed as a telehealth organization for personalizing the wellness experience for its customers.

Its Hims and Hers portfolio includes sexual health, mental health, dermatology, and even primary care products. Most notably, its “Hims” branded supplements were heavily marketed to men with erectile dysfunction, anxiety, and other disorders. Still, it has since expanded to include an array of different offerings.

Despite recent deals with the likes of Uber (for on-demand delivery), Walmart, and even Walgreens, HIMS stock has been unable to mount any bullishness in the market. That has led to a drop in share price to as low as $4.07 this month. We’ve discussed some of the more significant achievements of the company over the last several months, with the latest launch of a new mobile platform taking a direct approach to its marketing program. Announced earlier this week, the app aims to “reshape” access and experience of modern healthcare.

“The Hims & Hers mobile app will allow our over 500,000 subscription Members a truly unique way to take ownership and control of their health and wellness, and we anticipate this Platform will be the foundation on which we build and invest in this future, further bundling additional value for our Members,” said Andrew Dudum, CEO and Co-Founder of Hims & Hers.

The Beachbody Company, Inc. (NYSE:BODY)

penny stocks, NASDAQ:SNAX, NASDAQ:ME, NASDAQ:BZFD, NYSE:HIMS, NYSE:BODY, CLICK HERE RIGHT NOW!

Do you know Tony Horton, or have you ever seen Shaun T infomercials? If you answered yes to either, then you’re familiar with The Beachbody Company. This fitness-focused organization is responsible for producing high-energy exercise programs and marketing them to the masses.

But after going public about a year ago, BODY stock hasn’t been able to carry the weight of the market. It briefly reached a high of $18.20, but since then, shares have slipped as low as $1.51. Amid a slew of analyst downgrades, mixed earnings, and slashed guidance, Beachbody hasn’t had the best experience in the public markets.

Regardless, the company continues delivering content and expanding its platform. Its Beachbody On-Demand Interactive subscription recently won Good Housekeeping’s 2022 Award for Best Classes on Demand. Will that help the company win over investors this year?

  • 5 Top Penny Stocks To Buy Now According To Reddit

In its last quarterly update, Carl Daikeler, Beachbody’s Co-Founder, Chairman, and Chief Executive Officer, said he was “ laser-focused on driving revenue growth, creating value for shareholders, and delivering on our mission,” so we’ll have to see what 2022 will have in store.

Household Penny Stocks To Watch

Whether you’re looking for a “bargain” or like to know how your favorite brands are doing in the stock market today, a little research can go a long way. These are just a handful of household names that are not only public; they’re also penny stocks (stocks under $5). The question for this year is will they remain at these levels in the long run, or will it become a classic growth story? For the second half of this list of penny stocks, check out the article: 5 Household Name Penny Stocks To Buy Under $5.

View this article on YouTube:


If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!


News Related

OTHER NEWS

Rel Capital resolution: Lenders hire KPMG India, L&L Partners

Lenders to Reliance Capital have appointed KPMG India as their process advisor andetL&L Partners the legal counsel to help negotiate the challenges in the resolution of Anil Ambani-promoted Reliance Capital, ... Read more »

Soaring refining margin bodes well for oil firms

The industrial complex in the southern port city of Ulsan where production bases of Korea’s major petrochemical companies are located (Yonhap)South Korean oil refiners’ key profitability measure has been rising ... Read more »

Buckle (BKE) Gains As Market Dips: What You Should Know

Buckle (BKE) closed at $37.24 in the latest trading session, marking a +1.36% move from the prior day. This change outpaced the S&P 500’s 0.37% loss on the day. – ... Read more »

AutoNation (AN) Dips More Than Broader Markets: What You Should Know

In the latest trading session, AutoNation (AN) closed at $103.57, marking a -0.46% move from the previous day. This change lagged the S&P 500’s 0.37% loss on the day. – ... Read more »

FuboTV Inc. (FUBO) Stock Moves -0.3%: What You Should Know

fuboTV Inc. (FUBO) closed at $10.07 in the latest trading session, marking a -0.3% move from the prior day. This change was narrower than the S&P 500’s 0.37% loss on ... Read more »

Fiverr International (FVRR) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Fiverr International (FVRR) closed at $81.01, marking a -0.52% move from the previous day. This change lagged the S&P 500’s daily loss of 0.37%. – ... Read more »

Sterling Construction (STRL) Gains As Market Dips: What You Should Know

Sterling Construction (STRL) closed at $27.51 in the latest trading session, marking a +1.63% move from the prior day. The stock outpaced the S&P 500’s daily loss of 0.37%. – ... Read more »

Boise Cascade (BCC) Gains As Market Dips: What You Should Know

Boise Cascade (BCC) closed at $77.20 in the latest trading session, marking a +0.69% move from the prior day. The stock outpaced the S&P 500’s daily loss of 0.37%. – ... Read more »

CRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should Know

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $62.36, marking a +0.76% move from the previous day. This move outpaced the S&P 500’s daily loss of 0.37%. ... Read more »

Bausch Health (BHC) Dips More Than Broader Markets: What You Should Know

Bausch Health (BHC) closed the most recent trading day at $24.39, moving -0.53% from the previous trading session. This move lagged the S&P 500’s daily loss of 0.37%. – Zacks ... Read more »

ETF Strategies to Consider for February as Fed's Rate Hike Nears

Wall Street has been mostly kind to investors so far in February after a tough January. Market participants are upbeat about improving U.S. economic conditions as reflected by encouraging fourth-quarter ... Read more »

Bank of Nova Scotia (BNS) Gains As Market Dips: What You Should Know

Bank of Nova Scotia (BNS) closed at $73.75 in the latest trading session, marking a +0.78% move from the prior day. This move outpaced the S&P 500’s daily loss of ... Read more »

Fox (FOXA) to Report Q2 Earnings: What's in the Offing?

Fox FOXA is set to report second-quarter fiscal 2022 results on Feb 9.For the quarter, the company’s current Zacks Consensus Estimate for earnings is pegged at breakeven against a loss ... Read more »

Generac Holdings (GNRC) Gains As Market Dips: What You Should Know

In the latest trading session, Generac Holdings (GNRC) closed at $279.97, marking a +0.01% move from the previous day. This move outpaced the S&P 500’s daily loss of 0.37%. – ... Read more »

Spirit And Frontier Announce $6.6 Billion Merger

Spirit Airlines Incorporated (NYSE:SAVE) and Frontier Group Holdings Inc (NASDAQ:ULCC) have announced a $6.6 billion merger to create one of the largest low-cost airlines in the U.S. The new airline ... Read more »

First Trust Energy AlphaDEX Fund (FXN) Hits a 52-Week High

The First Trust Energy AlphaDEX Fund FXN is probably a suitable pick for investors looking for momentum. FXN hit a 52-week high and is up 59.6% from its 52-week low ... Read more »

Meta Threatens To Close Facebook And Instagram In Europe Over Data Scramble

In a document filed with the U.S. Securities and Exchange Commission (SEC), Meta Platforms Inc (NASDAQ:FB) has warned it could be forced to close Facebook and Instagram in Europe if ... Read more »

Stock futures inch higher after S&P, Nasdaq fall to start the week

U.S. stock index futures crept higher during overnight trading Monday, after the major averages moved between gains and losses during regular trading as the market awaits key inflation data later ... Read more »

How a To-Don't List Can Help You Achieve Your Goals

To-do lists are helpful tools for many people, but they can quickly take over our lives, making daily living feel like just another item to cross off of a never-ending ... Read more »

Immunovant (IMVT) Reports Wider-Than-Expected Loss in Q3

Immunovant, Inc. IMVT reported a net loss of 36 cents per share in the third quarter of fiscal 2022 (ended Dec 31, 2021), wider than the Zacks Consensus Estimate of ... Read more »

Buckle's (BKE) Sales Run Continues in January, Comps Gain 4.2%

The Buckle, Inc. BKE looks well poised on the back of its robust strategic efforts, including strength in e-commerce business and an impressive sales trend. BKE has been putting up ... Read more »

6 Best-Leveraged ETF Areas of Last Week

Wall Street put up a moderate show last week with the S&P 500 (up 1.6%), the Dow Jones (up 1.1%), the Nasdaq Composite (up 2.4%) and the Russell 2000 (up ... Read more »

Interpublic (IPG) to Report Q4 Earnings: What's in the Cards?

The Interpublic Group of Companies, Inc. IPG is scheduled to report fourth-quarter 2021 results on Feb 10, before the opening bell. – Zacks Let’s check out how things have shaped ... Read more »

Mednax (MD) Buys Night Lite Pediatrics to Boost Portfolio

Mednax, Inc. MD and its affiliated practices Pediatrix Medical Group recently acquired Night Lite Pediatrics, LLC in Orlando, FL. Night Lite is a private 13-clinic pediatric urgent care practice. The ... Read more »

Best Growth Stocks to Buy for February 7th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, February 7th: – Zacks Apple AAPL: This company whose business primarily runs around its ... Read more »

Gol Linhas (GOL) Stock up 16.2% in a Month: More Upside Left?

Shares of Gol Linhas GOL have displayed an uptrend on the bourses over the past month, gaining 16.2% against its industry’s 3.1% decline. – Zacks Image Source: Zacks Investment Research ... Read more »

Top Research Reports for Bank of America, Coca-Cola & salesforce

Monday, February 7, 2022 The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including Bank ... Read more »

Sanofi's (SNY) Enjaymo Gets FDA Nod For Rare Blood Disorder

Sanofi SNY announced that the FDA has approved its monoclonal antibody, Enjaymo (sutimlimab-jome), to decrease the need for red blood cell transfusion due to hemolysis in adult patients with cold ... Read more »

The Zacks Analyst Blog Highlights: Alphabet, T-Mobile US, Advanced Micro Devices, Mondelez International and Chubb

For Immediate Release Chicago, IL – February 7, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ... Read more »

IRS to stop using facial recognition for identity verification

Signage outside the Internal Revenue Service (IRS) headquarters in Washington, D.C.Bloomberg | Bloomberg | Getty Images The IRS on Monday announced it will stop using a controversial third-party service for ... Read more »

Why Mid-America Apartment Communities (MAA) is a Great Dividend Stock Right Now

Whether it’s through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you’re an income investor, your primary focus is ... Read more »

On Core Values, Self-Honesty and Having Fun with Jairek Robbins, the New President of SUCCESS

“You gotta answer your DMs, man,” says Jairek Robbins, half laughing, in his latest Brilliant Thoughts interview with Tristan Ahumada. Robbins, who is an acclaimed business coach, best-selling author and ... Read more »

Surging Earnings Estimates Signal Upside for Xilinx (XLNX) Stock

Investors might want to bet on Xilinx (XLNX), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and ... Read more »

BCB Bancorp (BCBP) is a Top Dividend Stock Right Now: Should You Buy?

Whether it’s through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you’re an income investor, your primary focus is ... Read more »

The Zacks Analyst Blog Highlights: AbbVie, Merck, Eli Lilly, Novartis and Pfizer

For Immediate Release Chicago, IL – February 7, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ... Read more »

BankUnited (BKU) Stock up 3.4% on New Share Repurchase Plan

BankUnited, Inc. BKU has announced a new share repurchase plan. The company’s board of directors has approved the repurchase of up to $150 million in shares of BKU’s outstanding stock. ... Read more »

TEGNA Inc. (TGNA) Soars 7.4%: Is Further Upside Left in the Stock?

TEGNA Inc. TGNA shares rallied 7.4% in the last trading session to close at $21.34. This move can be attributable to notable volume with a higher number of shares being ... Read more »

Can BCB Bancorp (BCBP) Run Higher on Rising Earnings Estimates?

BCB Bancorp (BCBP) could be a solid choice for investors given the company’s remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue ... Read more »

Earnings Estimates Moving Higher for Marathon Oil (MRO): Time to Buy?

Marathon Oil (MRO) could be a solid choice for investors given the company’s remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue ... Read more »

Transport ETFs to Buy on Solid Q4 Earnings

The fourth-quarter earnings picture for the transportation sector has been robust. This is especially true as earnings of 95.2% of the market capitalization of the sector that has reported so ... Read more »